Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. - Wikidata - wikimedia - TriplyDB

Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

http://www.wikidata.org/entity/Q37634491

about

Survivin and angiotensin-converting enzyme polymorphisms with risk of colorectal cancer: a systematic review and meta-analysis Lack of an association between angiotensin receptor blocker based therapy and increased risk of cancer: evidence from large observational studies Renin-angiotensin system blockade for the risk of cancer and death.Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery.Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis.Development of a Novel Scoring System for Predicting the Risk of Colorectal Neoplasia: A Retrospective Study Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study.KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies.Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study.Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression.Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cancer.The relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism and digestive cancer risk: Insights from a meta-analysis.The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.Alpha-glucosidase inhibitor use is associated with decreased colorectal neoplasia risk in patients with type 2 diabetes mellitus receiving colonoscopy: a retrospective study.Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma.

P2860

Q27013718-E39E8A30-948A-440A-857F-9C77E75F2216 Q28544725-CA180310-9978-40AD-AAD8-335520609738 Q30249043-C8D2F5A3-4CD7-4B8A-8F90-FFB94F08BBCE Q35637149-C1EDE013-5FDE-4CA9-901C-030291BED905 Q35665360-6E875D4C-8761-4346-95BF-92EE5F520148 Q36047981-6450772B-7B77-40EA-AC8A-C42B29046018 Q37409359-BC0E7505-A530-476B-8EA0-CDB15E844B53 Q37662217-332AB99B-5A93-4D69-93DB-CFE748840980 Q37709450-95B6ABD0-7E97-4B01-8303-E613A39B268F Q38386616-6C5D8FFF-2FFB-4274-8DE9-16B358D20D98 Q38698770-75E792F4-7579-461E-81E0-D475F40725C4 Q40462627-4B1AF779-DA7F-4729-B6AE-18B40D3FB839 Q40922671-7728DE12-9E60-42B0-9216-4FC16DCC48A0 Q41851530-F62F2F75-51F2-4FF7-A77D-CBE3CB9FED5A Q47107250-88CF5936-C846-4CA3-A524-F051D42507BC Q47146612-2B4EE5CC-95C6-4EB7-8BC5-25F36B4E035F Q47629815-0D6D861F-C770-4B02-A402-F95CAB01914C Q49134863-BC6EAC3D-BA56-4FF2-8C8C-55083F316351

P2860

Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

http://www.wikidata.org/entity/Q37634491

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

@en

Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

@nl

type

label

Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

@en

Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

@nl

prefLabel

Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

@en

Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

@nl

P1433

Q37634491-3D444C2B-75F0-4150-9D55-875053C5CDBB

P1476

Q37634491-F32D078E-8B6F-461F-9BD1-5FEBA4F3ABC1

P2093

Q37634491-47CCD068-AB9C-441F-978B-4518DF4107AA

Q37634491-4E1F7D52-E3E8-444F-B92A-4B0284971755

Q37634491-960F7374-87DC-4E77-BD04-411136A62FDE

P2860

Q37634491-00B02496-A31B-4506-89CB-249DD135FE15

Q37634491-0356F0FA-EF43-449C-8645-8A4F1D0B88B3

Q37634491-06AADA3D-B5F2-4274-A291-E3C228ECF2F7

Q37634491-07899DFC-2063-4148-9CE7-9DBEC22B65C4

Q37634491-427406DE-6481-4F1E-BD89-60DD1FE47950

Q37634491-4833F689-80C6-49D1-9C60-E66104D25BF6

Q37634491-502A4AD8-A268-4009-A868-B396756CA3B8

Q37634491-54138E26-7D6F-4E7F-8391-153D0310F81A

Q37634491-6BA47A36-D7D0-4B84-A8B7-26FEB1FA5068

Q37634491-6E4DAE90-946E-4C28-BF3C-E48F2FD9479C

P304

Q37634491-1F36965F-0FAE-4BD6-9DEC-31ECE1751C25

P31

Q37634491-B7EEAE4D-9A05-42A8-9C0B-378542215993

P356

Q37634491-92DC706F-0017-4022-9C66-139FCD1D8869

P407

Q37634491-D10C501D-AD4B-4108-BA36-96A92C4600D5

P433

Q37634491-CF9DF762-EB4B-4086-BCDF-778E1E272523

P478

Q37634491-9E5D43A2-10CE-4D1D-885B-8321ED856922

P577

Q37634491-71CAC8A6-1F23-4E80-8506-6CEF086214C7

P698

Q37634491-B4CAD348-4320-4B3F-B679-3D8985054E35

P921

Q37634491-F9DB1182-A8E4-4E17-904B-3BAA6449A944

P932

Q37634491-275BD536-E89F-4117-B174-4EDCDC6402B1

P356

P1433

Journal of the National Cancer Institute

P1476

Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.

@en

P2093

George A Makar

http://www.w3.org/2001/XMLSchema#string

John H Holmes

http://www.w3.org/2001/XMLSchema#string

Yu-Xiao Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs

Chronic proton pump inhibitor therapy and the risk of colorectal cancer

Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

Cardiovascular medication use and risk for colorectal cancer.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review.

Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.

ANG II stimulates PKC-dependent ERK activation, DNA synthesis, and cell division in intestinal epithelial cells.

Renin in blood vessels in human pulmonary tumors. An immunohistochemical and biochemical study.

P304

djt374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJT374

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24431411

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3952198

http://www.w3.org/2001/XMLSchema#string